Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB PP&E (Net)

PP&E (Net) at other companies

Illumina logo
IlluminaILMN
$755M-3.5%
Revvity logo
RevvityRVTY
$465.64M-4.3%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$146.93M-11.7%
Agilent Technologies logo
Agilent TechnologiesA
$2.1B+9.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$10.66B+14.2%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$111.23M+14.5%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's PP&E (net)?
Pacific Biosciences of California (PACB) reported PP&E (net) of $24.38M in Q1 2026.
How has Pacific Biosciences of California's PP&E (net) changed year-over-year?
Pacific Biosciences of California's PP&E (net) decreased by 1.7% year-over-year, from $24.79M to $24.38M.
What is the long-term trend for Pacific Biosciences of California's PP&E (net)?
Over 5 years (2020 to 2025), Pacific Biosciences of California's PP&E (net) has grown at a -0.6% compound annual growth rate (CAGR), from $24.9M to $24.15M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.